MYC and acute myeloid leukemia: Additionally, Pyzer et al. reported that AML induces the release of the c-Myc protein through MUC1-C signaling, which inhibits the expression of miR34a, driving the proliferation of MDSCs, the levels of PD-L1, and immunosuppressive functions [166].